-
Mashup Score: 0
The use of GLP-1 receptor agonists corresponded with a lower risk for depression among older adults with type 2 diabetes compared with dipeptidyl peptidase 4 inhibitors, results of a target trial emulation study suggested.GLP-1s did not reduce the risk for depression compared with sodium-glucose cotransporter 2 (SGLT2) inhibitors, another frequently prescribed diabetes treatment, according to
Source: www.healio.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 20
Observational data have suggested a link between glucagon-like peptide-1 (GLP-1)–receptor agonists and severe depression; however, convincing evidence
Source: www.jwatch.orgCategories: General Medicine News, General HCPsTweet
💊The use of GLP-1s was tied to a lower risk for #depression among older adults with type 2 #diabetes compared with DDP-4s. Read more about the findings, which align with past research, here: https://t.co/8WUUIauPtJ